secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytoDyn Inc. (CYDY)
CIK:        0001175680
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001558370-23-018526
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoDyn shareholders approve authorized common stock increase to 1.75B shares
-----------------------------------------------------------------------------

- Authorized shares increased from 1.35B to 1.75B, approved by 504.7M for vs 42.6M against.
- All five director nominees elected: Tanya Durkee Urbach, Stephen Simes, Ryan Dunlap, Lishomwa Ndhlovu, Karen Brunke.
- Advisory vote on named executive officer compensation passed with 297.5M for, 63.6M against, 14.2M abstentions.
- Share increase effective immediately upon filing Certificate of Amendment with Delaware Secretary of State on Nov 9, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175680/000155837023018526/0001558370-23-018526-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175680/000155837023018526/cydy-20231109x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-018526

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer